Skip to main content

Table 1 Demographic and clinical characteristics of included patients

From: The fate of indeterminate liver lesions: What proportion are precursors of hepatocellular carcinoma?

 

Patients who developed HCC (n = 19)

Patients who did not develop HCC (n = 90)

All patients (n = 109)

P value

Age (mean, SD)

54.2 (± 10.0)

51.8 (± 15.1)

52.4 (± 14.5)

0.398

Sex; n (%)

   

0.385

 Male

12 (63.2%)

47 (52.2%)

59 (54.1%)

 Female

7 (36.8%)

43 (47.8%)

50 (45.9%)

BMI (mean, SD)

27.6 (± 3.9)

27.7 (± 5.5)

27.7 (± 5.3)

0.990

Ethnicity; n (%)

 White

15 (78.9%)

49 (54.4%)

64 (58.7%)

 

 Black

1 (5.3%)

18 (20%)

19 (17.4%)

 

 Asian

2 (10.5%)

11 (12.2%)

13 (11.9%)

 

 Other

1 (5.3%)

10 (11.1%)

11 (10.1%)

 

 Mixed

0 (0%)

1 (1.1%)

1 (0.9%)

 

 Missing

0 (0%)

1 (1.1%)

1 (0.9%)

 

Smoking status; n (%)

 Non-smoker

9 (47.4%)

61 (67.8%)

70 (64.2%)

 

 Smoker

7 (36.8%)

19 (21.1%)

26 (23.9%)

 

 Ex-smoker

3 (15.8%)

8 (8.9%)

11 (10.1%)

 

 Missing

0 (0%)

2 (2.2%)

2 (1.8%)

 

Main aetiology; n (%)

 HCV

10 (52.6%)

29 (32.2%)

39 (35.8%)

 

 HBV

2 (10.5%)

12 (13.3%)

14 (12.8%)

 

 HBV/HDV

0 (0%)

6 (6.7%)

6 (5.5%)

 

 ArLD

4 (21.1%)

6 (6.7%)

10 (9.2%)

 

 NAFLD/NASH

0 (0%)

6 (6.7%)

6 (5.5%)

 

 Autoimmune

1 (5.3%)

2 (2.2%)

3 (2.8%)

 

 Other

2 (10.5%)

29 (32.2%)

31 (28.4%)

 

Alcohol consumption

   

0.023

 ≤ 14 U/week

94 (86.2%)

80 (88.9%)

14 (73.7%)

 

 > 14 U/week

12 (11%)

7 (7.8%)

5 (26.3%)

 

 Missing

3 (2.8%)

3 (3.3%)

0

 

Cirrhosis; n (%)

19 (100%)

69 (76.7%)

88 (80.7%)

0.019

Other malignancy; n (%)

0 (0%)

4 (4.4%)

4 (3.7%)

0.346

Family history of HCC; n (%)

0 (0%)

3 (3.5%)

3 (2.9%)

0.409

ALT (unit/l)

49 (IQR 46.5)

45 (IQR 67.3)

45 (IQR 61)

0.531

AST (unit/l)

52 (IQR 22.5)

51 (IQR 58.3)

51 (IQR 53)

0.227

ALP (unit/l)

101 (IQR 36)

96 (IQR 65.3)

96 (IQR 63)

0.333

Albumin (gram/l)

40.3 (± 4.5)

43.2 (± 4.7)

42.6 (± 4.5)

0.014

Platelet count (× 109/l)

90 (IQR 77)

157 (IQR 89.8)

148 (IQR 95.5)

 < 0.001

AFP (kunits/l)

8.9 (IQR 17)

4 (IQR 5)

4.4 (IQR 7)

0.074

Description of index lesion(s); n(%)

 Arterialised

15 (78.9)

63 (70.0)

78 (71.6)

0.432

 Dysplastic

1 (5.3)

1 (1.1)

2 (1.8)

0.220

 Indeterminate

15 (78.9)

77 (85.6)

92 (84.4)

0.471

 Regenerative

4 (21.1)

22 (24.4)

26 (23.9)

0.753

 Perfusional changes

0 (0)

7 (7.8)

7 (6.4)

0.209

  1. AFP, alphafetoprotein; ArLD, alcohol-related liver disease; ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; HDV, hepatitis delta virus; NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis